Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

 134.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 139.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 4,023
  • Market Cap: £140.39m
  • RiskGrade: 72
  • Beta: 0.00

Latest ShareCast News

Cello Health revenues and headline profits grow in Q1

By Iain Gilbert

Date: Wednesday 08 May 2019

(Sharecast News) - Healthcare-focused advisory group Cello Health saw like-for-like net revenue and headline pre-tax profits grow in the first quarter of its trading year, something it expects to carry over into the second quarter.

Cello Health sees strong like-for-like growth in 2018

By Josh White

Date: Thursday 17 Jan 2019

(Sharecast News) - Healthcare-led advisory group Cello Health updated the market for the year ended 31 December on Thursday, reporting that it traded "well" in 2018, with continued strong like-for-like growth from Cello Health somewhat offset by a slower outcome from Cello Signal.

Cello Health injects pharma duo to board of directors

By Duncan Ferris

Date: Thursday 16 Aug 2018

(Sharecast News) - Healthcare advisory group Cello Health on Thursday appointed independent non-executive directors Clifford Tompsett and Jo LeCouilliard to its board of directors.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 134.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 139.50
52 Week Low 96.00
Volume 4,023
Shares Issued 104.77m
Market Cap £140.39m
Beta 0.00
RiskGrade 72

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Price Trend
56.31% above the market average56.31% above the market average56.31% above the market average56.31% above the market average56.31% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income
8.07% below the market average8.07% below the market average8.07% below the market average8.07% below the market average8.07% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Growth
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average21.21% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 25-Apr-19 04-Oct-18
Paid 24-May-19 02-Nov-18
Amount 2.75p 1.10p

Trades for 14-Jun-2019

Time Volume / Share Price
14:34 9 @ 133.50p
14:12 1,364 @ 133.00p
13:25 1,100 @ 133.04p
09:43 992 @ 133.04p
09:14 167 @ 133.50p

Cello Health Key Personnel

CEO Mark Scott

Top of Page